<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <latestAction>
      <text>Read twice and referred to the Committee on Commerce, Science, and Transportation.</text>
      <links />
      <actionDate>2016-04-11</actionDate>
    </latestAction>
    <policyArea>
      <name>Commerce</name>
    </policyArea>
    <amendments />
    <relatedBills>
      <item>
        <latestAction>
          <actionDate>2016-09-22</actionDate>
          <text>Referred to the House Committee on Energy and Commerce.</text>
        </latestAction>
        <congress>114</congress>
        <latestTitle>Contact Lens Consumer Health Protection Act of 2016</latestTitle>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <type>HR</type>
        <number>6157</number>
      </item>
    </relatedBills>
    <billNumber>2777</billNumber>
    <updateDate>2016-11-02T23:47:10Z</updateDate>
    <sponsors>
      <item>
        <fullName>Sen. Cassidy, Bill [R-LA]</fullName>
        <firstName>Bill</firstName>
        <lastName>Cassidy</lastName>
        <identifiers>
          <lisID>1925</lisID>
          <gpoId>7964</gpoId>
          <bioguideId>C001075</bioguideId>
        </identifiers>
        <state>LA</state>
        <middleName />
        <party>R</party>
        <byRequestType />
        <bioguideId>C001075</bioguideId>
      </item>
    </sponsors>
    <notes />
    <originChamber>Senate</originChamber>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Consumer affairs</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Hearing, speech, and vision care</name>
          </item>
          <item>
            <name>Marketing and advertising</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Product safety and quality</name>
          </item>
          <item>
            <name>Retail and wholesale trades</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Commerce</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <chamber>Senate</chamber>
          <systemCode>sscm00</systemCode>
          <activities>
            <item>
              <date>2016-04-11T22:00:59Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <type>Standing</type>
          <name>Commerce, Science, and Transportation Committee</name>
        </item>
      </billCommittees>
    </committees>
    <cosponsors>
      <item>
        <identifiers>
          <lisID>1687</lisID>
          <bioguideId>B001236</bioguideId>
          <gpoId>8247</gpoId>
        </identifiers>
        <middleName />
        <fullName>Sen. Boozman, John [R-AR]</fullName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <firstName>John</firstName>
        <sponsorshipWithdrawnDate />
        <state>AR</state>
        <bioguideId>B001236</bioguideId>
        <sponsorshipDate>2016-04-11</sponsorshipDate>
        <party>R</party>
        <lastName>Boozman</lastName>
      </item>
      <item>
        <identifiers>
          <lisID>2286</lisID>
          <gpoId />
          <bioguideId>P000612</bioguideId>
        </identifiers>
        <middleName>Alfred</middleName>
        <fullName>Sen. Perdue, David [R-GA]</fullName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <firstName>David</firstName>
        <sponsorshipWithdrawnDate />
        <state>GA</state>
        <bioguideId>P000612</bioguideId>
        <sponsorshipDate>2016-04-21</sponsorshipDate>
        <party>R</party>
        <lastName>Perdue</lastName>
      </item>
    </cosponsors>
    <calendarNumbers />
    <committeeReports />
    <congress>114</congress>
    <title>Contact Lens Consumer Health Protection Act of 2016</title>
    <introducedDate>2016-04-11</introducedDate>
    <actions>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <item>
        <actionDate>2016-04-11</actionDate>
        <committee>
          <name>Commerce, Science, and Transportation Committee</name>
          <systemCode>sscm00</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Commerce, Science, and Transportation.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2016-04-11</actionDate>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <links />
        <actionCode>10000</actionCode>
        <committee />
      </item>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <summaries>
      <billSummaries>
        <item>
          <actionDate>2016-04-11</actionDate>
          <updateDate>2016-04-11T04:00:00Z</updateDate>
          <name>Introduced in Senate</name>
          <lastSummaryUpdateDate>2016-08-08T20:40:45Z</lastSummaryUpdateDate>
          <versionCode>00</versionCode>
          <actionDesc>Introduced in Senate</actionDesc>
          <text><![CDATA[<p><b>Contact Lens Consumer Health Protection Act of 2016</b></p> <p>This bill amends the Fairness to Contact Lens Consumers Act to require contact lens sellers to provide a toll-free telephone number and email address that prescribers can use to ask questions about a seller's prescription verification request.</p> <p>Under current law, a prescription is considered verified if the prescriber fails to communicate with the seller within eight business hours after receiving the seller-provided verification information. The bill requires the prescription to be considered unverified until the seller obtains affirmative confirmation of the accuracy of the prescription from the prescriber in cases where a prescriber communicates a question or concern about the accuracy or verification of the prescription to a seller through the toll-free telephone service or email address before the end of that eight-hour period. </p> <p>The bill removes the Federal Trade Commission's authority to adjust the eight-hour period. </p> <p>If a prescriber communicates a question or concern about the accuracy of a prescription before the deadline: (1) the seller shall not fill the prescription, and (2) the prescriber shall provide the seller with an accurate prescription.</p> <p>Sellers must offer prescribers different communication methods that the prescribers may select as their preferred method for verification requests.</p> <p>The bill allows a seller to alter a prescription only if: (1) a private label contact lens is included on the prescription and the same contact lens is manufactured by the same company and sold under multiple labels to individual providers; and (2) the seller fills the prescription with a contact lens of exactly the same material, design, and power as manufactured by that company under another label.</p> <p>Sellers must maintain a database of the issuance and expiration dates of each prescription they receive. The bill prohibits advertisements representing that a contact lens prescription may be filled after the prescription expires.</p> <p>Sellers violating certain prescriber verification requirements are subject to increased penalties of up to $40,000 per violation. Such requirements apply to all contact lens sales in the United States, notwithstanding where the seller is located. </p> <p>The Centers for Disease Control and Prevention must examine the potentially adverse effects of seller violations on consumers.</p>]]></text>
        </item>
      </billSummaries>
    </summaries>
    <laws />
    <createDate>2016-04-12T05:18:21Z</createDate>
    <titles>
      <item>
        <title>Contact Lens Consumer Health Protection Act of 2016</title>
        <chamberName />
        <chamberCode />
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
      </item>
      <item>
        <title>A bill to modernize the prescription verification process for contact lenses, to clarify consumer protections regarding false advertising of contact lenses, and for other purposes.</title>
        <chamberName />
        <chamberCode />
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
      </item>
      <item>
        <title>Contact Lens Consumer Health Protection Act of 2016</title>
        <chamberName />
        <chamberCode />
        <titleType>Display Title</titleType>
        <parentTitleType />
      </item>
    </titles>
    <cboCostEstimates />
    <recordedVotes />
    <billType>S</billType>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

